03 August 2020 | News
Investment builds on Advent’s expertise in the pharmaceuticals sector
Image credit- shutterstock.com
Mumbai based Advent International, one of the largest and most experienced global private equity investors, has announced that it has signed a definitive agreement to acquire a controlling stake in RA Chem Pharma Limited, a vertically integrated pharmaceutical company from Micro Labs Limited.
Founded in 2003 in Hyderabad, India, RA Chem Pharma is one of the most rapidly growing pharmaceutical companies in India. While the core focus is API, over time the company has forward integrated into Pellets, Formulations and Clinical Research to provide end-to-end offerings to its customers. Its product portfolio ranges from pharmaceuticals to niche areas of Animal health and Cosmeceuticals; supported by four manufacturing units, two R&D laboratories and a clinical research facility.
Advent has committed over $1.7 billion globally in six companies across the healthcare sector in the last 12 months. The firm has also committed more than $700 million in seven Indian businesses over the same period in varied sectors such as healthcare, consumer, and financial services amongst others.